Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Feb 14, 2019 - BMY vs. AZN: Which Stock Is the Better Value Option?
Feb 14, 2019 - AstraZeneca (AZN) beats earnings and sales estimates in the fourth quarter and provides encouraging outlook for 2019. Shares up.
Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
Feb 27, 2019 - Bayer's (BAYRY) fourth-quarter 2018 core earnings per share of 31 cents, per American Depositary Receipt ("ADR"), beat the Zacks Consensus Estimate of 26 cents.
Feb 27, 2019 - Mallinckrodt (MNK) tops earnings and sales estimates in the fourth quarter leading to a gain in share price.
Mar 11, 2019 - Sanofi (SNY) and partner Regeneron's (REGN) Dupixent gets FDA's priority review status for inadequately controlled severe chronic rhinosinusitis with nasal polyps.
Mar 14, 2019 - Does Astrazeneca (AZN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Mar 14, 2019 - Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.
Mar 15, 2019 - Merck (MRK) receives approval for Keytruda's combo therapy for first-line treatment of metastatic squamous non-small cell lung cancer population in Europe.